Botanical species · safety record

Ochrosia borbonica

The EFSA Compendium of Botanicals holds 3 constituent measurements for Ochrosia borbonica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ochrosia borbonica J.F.Gmel.

3Constituent measurements

0Safety records

3Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Bark	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Indole alkaloids	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Alkaloids	Unspecified	Solvent extraction	—	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

SVOBODA, GH., POORE, GA., MONTFORT, ML. ALKALOIDS OF OCHROSIA MACULATA JACQ (OCHROSIA BORBONICA GMEL). Journal of pharmaceutical sciences, 1968, vol. 57, no. 10, p. 1720-&. DOI
Zhang, Bing-Jie., Yan, Ju-Ming., Wu, Zi-Kun., Liu, Ya-Ping., Bao, Mei-Fen., Cheng, Gui-Guang., Luo, Xiao-Dong., Cai, Xiang-Hai., Li, Yan. Alkaloids from Ochrosia borbonica. Helvetica chimica acta, 2013, vol. 96, no. 12, p. 2288-2298. DOI
Le Men, J., Hayat, M., Mathe, G., Guillon, J. C., Chenu, E., Humblot, M., Masson, Y. Methoxy-9-ellipticine lactate. I. Experimental study (oncostatic and immunosupressive actions; preclinical pharmacology). Revue europeenne d'etudes cliniques et biologiques, 1970, p. 534-538.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature